tiprankstipranks
Trending News
More News >
Lifemd, Inc. (LFMD)
:LFMD
US Market

LifeMD (LFMD) Stock Forecast & Price Target

Compare
594 Followers
See the Price Targets and Ratings of:

LFMD Analyst Ratings

Strong Buy
8Ratings
Strong Buy
7 Buy
1 Hold
0 Sell
Based on 8 analysts giving stock ratings to
LifeMD
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

LFMD Stock 12 Month Forecast

Average Price Target

$11.57
▲(0.26%Upside)
Based on 8 Wall Street analysts offering 12 month price targets for LifeMD in the last 3 months. The average price target is $11.57 with a high forecast of $15.00 and a low forecast of $7.00. The average price target represents a 0.26% change from the last price of $11.54.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3":"$3","16":"$16","6.25":"$6.25","9.5":"$9.5","12.75":"$12.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$15.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":11.57,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$11.57</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$7.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3,6.25,9.5,12.75,16],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.44,8.021538461538462,8.603076923076923,9.184615384615386,9.766153846153847,10.34769230769231,10.92923076923077,11.510769230769231,12.092307692307692,12.673846153846155,13.255384615384617,13.836923076923078,14.418461538461539,{"y":15,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.44,7.757692307692308,8.075384615384616,8.393076923076924,8.71076923076923,9.028461538461539,9.346153846153847,9.663846153846155,9.981538461538461,10.29923076923077,10.616923076923078,10.934615384615384,11.252307692307692,{"y":11.57,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.44,7.406153846153846,7.372307692307692,7.338461538461539,7.304615384615385,7.270769230769231,7.236923076923077,7.203076923076924,7.1692307692307695,7.135384615384615,7.101538461538461,7.067692307692308,7.033846153846154,{"y":7,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":10.2,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.64,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.25,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.8,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.69,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.07,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.32,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.54,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.95,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.57,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.26,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.43,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.44,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$15.00Average Price Target$11.57Lowest Price Target$7.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on LFMD
TipRanks AITipRanks
Not Ranked
TipRanks
$9
Hold
-22.01%
Downside
Reiterated
05/14/25
LifeMD's stock score reflects strong revenue growth and a positive outlook from the recent earnings call, but is tempered by ongoing financial challenges like negative equity and net losses. The technical analysis shows upward momentum, but valuation concerns persist due to a negative P/E ratio and lack of dividends. The strategic acquisition in women's health offers potential upside.
BTIG
$12$15
Buy
29.98%
Upside
Reiterated
05/29/25
BTIG Remains a Buy on LifeMD (LFMD)
Lake Street Analyst forecast on LFMD
Brooks O'NeilLake Street
Lake Street
$12
Buy
3.99%
Upside
Reiterated
05/22/25
Lake Street Sticks to Their Buy Rating for LifeMD (LFMD)
Cantor Fitzgerald Analyst forecast on LFMD
Sarah JamesCantor Fitzgerald
Cantor Fitzgerald
$15
Buy
29.98%
Upside
Reiterated
05/07/25
Cantor Fitzgerald reiterates Overweight Rating on LifeMD Inc (LFMD)Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $15.00 price target on LifeMD Inc (NASDAQ: LFMD).
Mizuho Securities Analyst forecast on LFMD
Steven ValiquetteMizuho Securities
Mizuho Securities
$7$8
Hold
-30.68%
Downside
Reiterated
05/07/25
LifeMD Inc (LFMD) PT Raised to $8 at MizuhoMizuho analyst Steven Valiquette raised the price target on LifeMD Inc (NASDAQ: LFMD) to $8.00 (from $7.00) while maintaining a Neutral rating.
H.C. Wainwright Analyst forecast on LFMD
Yi ChenH.C. Wainwright
H.C. Wainwright
$14
Buy
21.32%
Upside
Reiterated
05/07/25
LifeMD's Strong Financial Performance and Strategic Initiatives Justify Buy Rating
KeyBanc
$7.5$7
Buy
-39.34%
Downside
Reiterated
04/16/25
LifeMD Inc (LFMD) PT Lowered to $7 at KeyBancKeyBanc analyst Steve Dechert lowered the price target on LifeMD Inc (NASDAQ: LFMD) to $7.00 (from $7.50) while maintaining a Overweight rating.
Freedom Capital Markets Analyst forecast on LFMD
Ilya ZubkovFreedom Capital Markets
Not Ranked
Freedom Capital Markets
$12$13
Buy
12.65%
Upside
Reiterated
03/18/25
LifeMD Inc (LFMD) PT Raised to $13 at Freedom BrokerFreedom Broker analyst Ilya Zubkov raised the price target on LifeMD Inc (NASDAQ: LFMD) to $13.00 (from $12.00) while maintaining a Buy rating
Craig-Hallum Analyst forecast on LFMD
Alex FuhrmanCraig-Hallum
Craig-Hallum
Buy
Reiterated
03/10/25
Craig-Hallum Sticks to Its Buy Rating for LifeMD (LFMD)
B.Riley Financial Analyst forecast on LFMD
Kyle BauserB.Riley Financial
B.Riley Financial
$11$12
Buy
3.99%
Upside
Reiterated
11/08/24
LifeMD price target raised to $12 from $11 at B. RileyLifeMD price target raised to $12 from $11 at B. Riley
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on LFMD
TipRanks AITipRanks
Not Ranked
TipRanks
$9
Hold
-22.01%
Downside
Reiterated
05/14/25
LifeMD's stock score reflects strong revenue growth and a positive outlook from the recent earnings call, but is tempered by ongoing financial challenges like negative equity and net losses. The technical analysis shows upward momentum, but valuation concerns persist due to a negative P/E ratio and lack of dividends. The strategic acquisition in women's health offers potential upside.
BTIG
$12$15
Buy
29.98%
Upside
Reiterated
05/29/25
BTIG Remains a Buy on LifeMD (LFMD)
Lake Street Analyst forecast on LFMD
Brooks O'NeilLake Street
Lake Street
$12
Buy
3.99%
Upside
Reiterated
05/22/25
Lake Street Sticks to Their Buy Rating for LifeMD (LFMD)
Cantor Fitzgerald Analyst forecast on LFMD
Sarah JamesCantor Fitzgerald
Cantor Fitzgerald
$15
Buy
29.98%
Upside
Reiterated
05/07/25
Cantor Fitzgerald reiterates Overweight Rating on LifeMD Inc (LFMD)Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $15.00 price target on LifeMD Inc (NASDAQ: LFMD).
Mizuho Securities Analyst forecast on LFMD
Steven ValiquetteMizuho Securities
Mizuho Securities
$7$8
Hold
-30.68%
Downside
Reiterated
05/07/25
LifeMD Inc (LFMD) PT Raised to $8 at MizuhoMizuho analyst Steven Valiquette raised the price target on LifeMD Inc (NASDAQ: LFMD) to $8.00 (from $7.00) while maintaining a Neutral rating.
H.C. Wainwright Analyst forecast on LFMD
Yi ChenH.C. Wainwright
H.C. Wainwright
$14
Buy
21.32%
Upside
Reiterated
05/07/25
LifeMD's Strong Financial Performance and Strategic Initiatives Justify Buy Rating
KeyBanc
$7.5$7
Buy
-39.34%
Downside
Reiterated
04/16/25
LifeMD Inc (LFMD) PT Lowered to $7 at KeyBancKeyBanc analyst Steve Dechert lowered the price target on LifeMD Inc (NASDAQ: LFMD) to $7.00 (from $7.50) while maintaining a Overweight rating.
Freedom Capital Markets Analyst forecast on LFMD
Ilya ZubkovFreedom Capital Markets
Not Ranked
Freedom Capital Markets
$12$13
Buy
12.65%
Upside
Reiterated
03/18/25
LifeMD Inc (LFMD) PT Raised to $13 at Freedom BrokerFreedom Broker analyst Ilya Zubkov raised the price target on LifeMD Inc (NASDAQ: LFMD) to $13.00 (from $12.00) while maintaining a Buy rating
Craig-Hallum Analyst forecast on LFMD
Alex FuhrmanCraig-Hallum
Craig-Hallum
Buy
Reiterated
03/10/25
Craig-Hallum Sticks to Its Buy Rating for LifeMD (LFMD)
B.Riley Financial Analyst forecast on LFMD
Kyle BauserB.Riley Financial
B.Riley Financial
$11$12
Buy
3.99%
Upside
Reiterated
11/08/24
LifeMD price target raised to $12 from $11 at B. RileyLifeMD price target raised to $12 from $11 at B. Riley
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering LifeMD

1 Month
xxx
Success Rate
15/31 ratings generated profit
48%
Average Return
+10.69%
reiterated a xxx
rating 15 hours ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 48.39% of your transactions generating a profit, with an average return of +10.69% per trade.
3 Months
xxx
Success Rate
11/16 ratings generated profit
69%
Average Return
+10.39%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 68.75% of your transactions generating a profit, with an average return of +10.39% per trade.
1 Year
Alex FuhrmanCraig-Hallum
Success Rate
10/16 ratings generated profit
63%
Average Return
+45.74%
reiterated a buy rating 3 months ago
Copying Alex Fuhrman's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +45.74% per trade.
2 Years
xxx
Success Rate
12/12 ratings generated profit
100%
Average Return
+80.07%
reiterated a xxx
rating 23 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +80.07% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

LFMD Analyst Recommendation Trends

Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
5
2
5
8
10
Buy
4
5
7
6
7
Hold
3
4
2
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
12
11
14
16
19
In the current month, LFMD has received 17 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. LFMD average Analyst price target in the past 3 months is 11.57.
Each month's total comprises the sum of three months' worth of ratings.

LFMD Financial Forecast

LFMD Earnings Forecast

Next quarter’s earnings estimate for LFMD is -$0.02 with a range of -$0.10 to $0.03. The previous quarter’s EPS was $0.01. LFMD beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 50.00% of the time in the same period. In the last calendar year LFMD has Outperformed its overall industry.
Next quarter’s earnings estimate for LFMD is -$0.02 with a range of -$0.10 to $0.03. The previous quarter’s EPS was $0.01. LFMD beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 50.00% of the time in the same period. In the last calendar year LFMD has Outperformed its overall industry.

LFMD Sales Forecast

Next quarter’s sales forecast for LFMD is $66.15M with a range of $65.09M to $67.71M. The previous quarter’s sales results were $65.70M. LFMD beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 50.82% of the time in the same period. In the last calendar year LFMD has Outperformed its overall industry.
Next quarter’s sales forecast for LFMD is $66.15M with a range of $65.09M to $67.71M. The previous quarter’s sales results were $65.70M. LFMD beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 50.82% of the time in the same period. In the last calendar year LFMD has Outperformed its overall industry.

LFMD Stock Forecast FAQ

What is LFMD’s average 12-month price target, according to analysts?
Based on analyst ratings, Lifemd, Inc.’s 12-month average price target is 11.57.
    What is LFMD’s upside potential, based on the analysts’ average price target?
    Lifemd, Inc. has 0.26% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is LFMD a Buy, Sell or Hold?
          Lifemd, Inc. has a consensus rating of Strong Buy which is based on 7 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Lifemd, Inc.’s price target?
            The average price target for Lifemd, Inc. is 11.57. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $15.00 ,the lowest forecast is $7.00. The average price target represents 0.26% Increase from the current price of $11.54.
              What do analysts say about Lifemd, Inc.?
              Lifemd, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.
                How can I buy shares of LFMD?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis